Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't play many pennies, do you? Float of 375 million is nothing around here.
Yep- EWDC is going to be fun tomorrow!
PMCL bounced 500% from its low so EWDC might have a long way to go tomorrow and Wednesday
EWDC- a holy crap gapper for tomorrow judging by L2
EWDC- I already can't wait for tomorrow morning
EWDC- ETRD on the bid- traders are getting now...
If EWDC closes near .003 today should be a huge gapper tomorrow- you know this is going to hit all the scans tonight.
EWDC- hard fill too- that's always a good sign. I missed PMCL, not going to miss this one. GL!
EWDC- I'm buying here- the MOMOs coming it looks like.
Was just looking at that one....
ummm..might as well fill your boots with cement.
Based on the chart do you want me to tell you what those funny feelings mean?
I wish PMCL would make up its mind...
DNDN hit that 13.35 high- good trading stock. Out again
Back in DNDN at 13.95 hoping for a 14.35 break next.
In DNDN @ 13.59, out at 13.91. Will get back in on a 13.94 break. GL
13.70 break on DNDN going to look really nice
Got me some DNDN here
I'm liking the PMCL chart this morning- very hard fill too.
Exactly- I wish there was some way to convince people that 95% of the time after a huge run there will USUALLY be a secondary bounce of some sort. After that, 99% of the time you're screwed if you're still in. I guess it's that 1% exception that keeps people doing this over and over.
ha ha...It just amazes me that people have the nerve to pump stocks that are at best very lackluster or, more often than not, in the middle of the plummeting stage.
That sucks- feel sorry for you. Just don't hold it below 7.75, ok? Not much support below there for a long way. GL
I'm sure we will....you'll be pumping this all the back down again.
Please give me a break...you sound pathetic. Why the heck would you pump something that looks like it's ready to start dropping like a rock???
Switch to Choicetrade. Rated 4 stars by Barrons- $5 trades- DAS platform- NO RESTRICTIONS on ANY stock.
The bigger the fall the larger the bounce.
WOW you got ripped off...lol
Over $500 million trade volume on DNDN- Holy Crap!
So where do we buy DNDN? This is going to be fun to flip today.
NWBT- got out at .154 with a nice profit- will be trading NWBT and DNDN all day- should be nice! GL!
WOW- NWBT 10X 10 daily avg volume. =30% and rising. .145x.15 2x2. This going to be agreat play all day on sympathy with DNDN. Can't believe no one in BB's Penny Haven is on this. CHECK THE CHART!
NWBT- holy crap- going to be a nice day. 6X 10 day avg volume in 4 minutes! Buy on the dip that should come- no resistance till .24!
old PR from 3/7
Northwest Biotherapeutics Adds UCLA as a Site to Its Pivotal Phase II Brain Cancer Trial
Wednesday March 7, 8:00 am ET
First UCLA Patient Surgery Performed
BOTHELL, Wash., March 7 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB - News), a biotechnology company focused on cancer immunotherapy, today announced that The University of California at Los Angeles (UCLA) has been added as a clinical site in its ongoing pivotal Phase II trial for DCVax®-Brain for patients with newly diagnosed Glioblastoma multiforme (GBM). The first UCLA surgery was performed by Dr. Linda Liau, M.D., Ph.D., the principal investigator of the clinical trial, and the Director of the Malignant Brain Tumor Program at the UCLA School of Medicine. The UCLA program is one of the leading brain cancer centers in the U.S., treating hundreds of such cases per year. The first UCLA surgery follows recent surgeries in this Phase II trial at Henry Ford Hospital. Nine other clinical trial sites are pending.
NWBT- major volume here! Chart breakout!
NWBT .135x.15
NWBT .12x.124! CHart is red hot for a breakout!
NWBT GAPPING up here- yes I"m excited! 3@.11x1@.124
NWBT UpTicking here- should pop hard on DNDN news. .11x.115
Northwest Biotherapeutics Adds UCLA as a Site to Its Pivotal Phase II Brain Cancer Trial
Wednesday March 7, 8:00 am ET
First UCLA Patient Surgery Performed
BOTHELL, Wash., March 7 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB - News), a biotechnology company focused on cancer immunotherapy, today announced that The University of California at Los Angeles (UCLA) has been added as a clinical site in its ongoing pivotal Phase II trial for DCVax®-Brain for patients with newly diagnosed Glioblastoma multiforme (GBM). The first UCLA surgery was performed by Dr. Linda Liau, M.D., Ph.D., the principal investigator of the clinical trial, and the Director of the Malignant Brain Tumor Program at the UCLA School of Medicine. The UCLA program is one of the leading brain cancer centers in the U.S., treating hundreds of such cases per year. The first UCLA surgery follows recent surgeries in this Phase II trial at Henry Ford Hospital. Nine other clinical trial sites are pending.
I have no idea- makes them feel special in their own little world....
Bid building on NWBT- chart is setup for a possible double today on the coat tails of the DNDN news. Really nice chart.
Northwest Biotherapeutics Adds UCLA as a Site to Its Pivotal Phase II Brain Cancer Trial
Wednesday March 7, 8:00 am ET
First UCLA Patient Surgery Performed
BOTHELL, Wash., March 7 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB - News), a biotechnology company focused on cancer immunotherapy, today announced that The University of California at Los Angeles (UCLA) has been added as a clinical site in its ongoing pivotal Phase II trial for DCVax®-Brain for patients with newly diagnosed Glioblastoma multiforme (GBM). The first UCLA surgery was performed by Dr. Linda Liau, M.D., Ph.D., the principal investigator of the clinical trial, and the Director of the Malignant Brain Tumor Program at the UCLA School of Medicine. The UCLA program is one of the leading brain cancer centers in the U.S., treating hundreds of such cases per year. The first UCLA surgery follows recent surgeries in this Phase II trial at Henry Ford Hospital. Nine other clinical trial sites are pending.
Yeah- some of these posters don't have one previous post about DNDN- that's the beauty of MBs....